1. Home
  2. SPRY vs LXFR Comparison

SPRY vs LXFR Comparison

Compare SPRY & LXFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$4.05

Market Cap

415.7M

Sector

Health Care

ML Signal

HOLD

Logo Luxfer Holdings PLC

LXFR

Luxfer Holdings PLC

SELL

Current Price

$17.26

Market Cap

465.6M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
SPRY
LXFR
Founded
2015
1898
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
415.7M
465.6M
IPO Year
2020
2002

Fundamental Metrics

Financial Performance
Metric
SPRY
LXFR
Price
$4.05
$17.26
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $22.50
N/A
AVG Volume (30 Days)
★ 1.4M
334.6K
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
★ 3.02%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.31
Revenue
$84,278,000.00
★ $384,600,000.00
Revenue This Year
$52.57
N/A
Revenue Next Year
$45.52
$6.26
P/E Ratio
★ N/A
$55.61
Revenue Growth
N/A
★ N/A
52 Week Low
$3.81
$11.26
52 Week High
$13.15
$19.45

Technical Indicators

Market Signals
Indicator
SPRY
LXFR
Relative Strength Index (RSI) 41.52 54.39
Support Level $3.91 $17.19
Resistance Level $4.60 $17.36
Average True Range (ATR) 0.25 0.04
MACD 0.05 -0.00
Stochastic Oscillator 27.26 71.43

Price Performance

Historical Comparison
SPRY
LXFR

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is engaged in materials engineering and the manufacture of materials, components, and gas containment products. The company has two reportable segments: Elektron and Gas Cylinders. The Elektron segment produces specialty materials based on magnesium and zirconium for applications in aerospace, defense, automotive, and industrial markets. The Gas Cylinders segment manufactures high-pressure gas containment products using aluminum alloys and carbon composite technologies for use in healthcare, emergency response, aerospace, and alternative fuel transportation markets.

Share on Social Networks: